BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22897235)

  • 21. Treatment of gastrointestinal stromal tumor with imatinib mesylate: a retrospective single-center experience in Heidelberg.
    Kasper B; Kallinowski B; Herrmann T; Lehnert T; Mechtersheimer G; Geer T; Ho AD; Egerer G
    Dig Dis; 2006; 24(1-2):207-11. PubMed ID: 16699280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation.
    Kang YK; Kang BW; Im SA; Lee JL; Park SR; Kang WK; Chang HM; Kim TW; Oh DY; Jung KH; Ryu MH
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):43-51. PubMed ID: 23053257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of clinicopathology and prognosis in 181 patients with gastrointestinal stromal tumors].
    Zhang Y; Cao H; Wang M; Shen DP; Shen ZY; Ni XZ; Wu ZY; Shen YY; Liu Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar; 12(2):150-4. PubMed ID: 19296250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Operative indications for relatively small (2-5 cm) gastrointestinal stromal tumor of the stomach based on analysis of 60 operated cases.
    Otani Y; Furukawa T; Yoshida M; Saikawa Y; Wada N; Ueda M; Kubota T; Mukai M; Kameyama K; Sugino Y; Kumai K; Kitajima M
    Surgery; 2006 Apr; 139(4):484-92. PubMed ID: 16627057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "Pediatric-type" gastrointestinal stromal tumors in adults: distinctive histology predicts genotype and clinical behavior.
    Rege TA; Wagner AJ; Corless CL; Heinrich MC; Hornick JL
    Am J Surg Pathol; 2011 Apr; 35(4):495-504. PubMed ID: 21358303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Primary, non-metastatic gastrointestinal stromal tumour surgery: results of the GRISK study].
    Artigas Raventós V; López Pousa A; Ortega Medina L; Díaz de Liaño Argüelles A; Fernández Hernández JÁ; Lucena de la Poza JL
    Cir Esp; 2013 Feb; 91(2):96-102. PubMed ID: 22748847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A multicentre retrospective cohort study of patients with gastrointestinal stromal tumors in Shandong Province].
    Ning L; Yan W; Zhang M; Gong H; Dai Y; Jiang L; Lin H; Zhang D; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):326-30. PubMed ID: 24760638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Audit of a series of 40 gastrointestinal stromal tumour cases.
    Hinz S; Pauser U; Egberts JH; Schafmayer C; Tepel J; Fändrich F
    Eur J Surg Oncol; 2006 Dec; 32(10):1125-9. PubMed ID: 16859873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.
    Joensuu H; Vehtari A; Riihimäki J; Nishida T; Steigen SE; Brabec P; Plank L; Nilsson B; Cirilli C; Braconi C; Bordoni A; Magnusson MK; Linke Z; Sufliarsky J; Federico M; Jonasson JG; Dei Tos AP; Rutkowski P
    Lancet Oncol; 2012 Mar; 13(3):265-74. PubMed ID: 22153892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of gastric gastrointestinal stromal tumors in Shandong Province: a midterm report of multicenter GISSG1201 study].
    Hou Q; Luo W; Li L; Dai Y; Jiang L; Wang A; Chu X; Li Y; Yang D; Lu C; Yao L; Cui G; Lin H; Chen G; Cui Q; Zhang H; Lun Z; Xia L; Su Y; Han G; Hui X; Wei Z; Sun Z; Guo H; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1025-1030. PubMed ID: 28900994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Stromal gastrointestinal tumors: retrospective study of 24 cases].
    Boudabous H; Chaker Y; Nouira R; Dziri C
    Tunis Med; 2013 Nov; 91(11):661-7. PubMed ID: 24343490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastrointestinal stromal tumors in Turkey: experiences from 3 centers.
    Selcukbiricik F; Yalçın S; Tural D; Erdamar S; Demir G; Doğusoy G; Mandel NM
    Onkologie; 2013; 36(1-2):18-24. PubMed ID: 23429327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gastrointestinal stromal tumors: clinicopathologic and survival evaluation in Rebagliati Hospital].
    Manrique MN; Soriano C; Yábar A; Frisancho O; Palacios AM
    Rev Gastroenterol Peru; 2012; 32(4):357-65. PubMed ID: 23307085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical intervention following imatinib treatment in patients with advanced gastrointestinal stromal tumors (GISTs).
    Sym SJ; Ryu MH; Lee JL; Chang HM; Kim TW; Kim HC; Kim KH; Yook JH; Kim BS; Kang YK
    J Surg Oncol; 2008 Jul; 98(1):27-33. PubMed ID: 18452195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognosis of gastrointestinal stromal tumors.
    Bertin M; Angriman I; Scarpa M; Mencarelli R; Ranzato R; Ruffolo C; Polese L; Iacobone M; D'Amico DF
    Hepatogastroenterology; 2007; 54(73):124-8. PubMed ID: 17419245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy and safety of adjuvant post-surgical therapy with imatinib in gastrointestinal stromal tumor patients with high risk of recurrence: interim analysis from a multicenter prospective clinical trial].
    Zhan WH; Wang PZ; Shao YF; Wu XT; Gu J; Li R; Wan DS; Ding KF; Shi YQ; Yu JR; Lu HS; Zou XM; Bi JW; Sun YH; Lu YF; Chen DD; Zhang XH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep; 9(5):383-7. PubMed ID: 17043955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients.
    Song Z; Wang JL; Pan YL; Tao DY; Gan MF; Huang KE
    Hepatogastroenterology; 2009; 56(89):149-53. PubMed ID: 19453047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrointestinal stromal tumors treatment in the Imatinib era. The role of fair indication.
    Vendettuoli M; Pironi D; Pontone S; Panarese A; La Gioia G; Arcieri S; Romani AM; Palazzini G; Filippini A
    Minerva Chir; 2012 Apr; 67(2):165-73. PubMed ID: 22487918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate.
    Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG
    Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy.
    Keun Park C; Lee EJ; Kim M; Lim HY; Choi DI; Noh JH; Sohn TS; Kim S; Kim MJ; Lee HK; Kim KM
    Ann Surg; 2008 Jun; 247(6):1011-8. PubMed ID: 18520229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.